| Literature DB >> 28204851 |
J Barrie1, S Jamdar1, M F Iniguez2, O Bouamra2, T Jenks2, F Lecky2,3, D A O'Reilly4,5.
Abstract
BACKGROUND: Over the last decade trauma services have undergone a reconfiguration in England and Wales. The objective is to describe the epidemiology, management and outcomes for liver trauma over this period and examine factors predicting survival.Entities:
Keywords: Centralisation; Hepatobiliary; Liver; Outcomes; Trauma
Mesh:
Substances:
Year: 2017 PMID: 28204851 PMCID: PMC5808051 DOI: 10.1007/s00068-017-0765-y
Source DB: PubMed Journal: Eur J Trauma Emerg Surg ISSN: 1863-9933 Impact factor: 3.693
Demographics, management and outcomes of isolated liver injury compared to polytrauma from 2005 to 2014
| Polytrauma | Isolated liver injury | |
|---|---|---|
| Age | 33.5 (23.4–48.8) | 33.8 (23.6–48.8) |
| Male | 2505 (72.3%) | 589 (65.2%) |
| Female | 960 (27.7%) | 314 (34.8%) |
| Blunt | 2961 (85.5%) | 582 (64.5%) |
| Penetrating | 504 (14.5%) | 321 (35.5%) |
| Liver Surgery | 193 (5.6%) | 48 (5.3%) |
| ISS | 29 (19–41) | 8 (4–12) |
| Alive | 2771 (80%) | 882 (97.7%) |
| Dead | 694 (20%) | 21 (2.3%) |
Clinical features and management of heptic trauma over five chronological time periods in the decade studied
| 2005–2006 | 2007–2008 | 2009–2010 | 2011–2012 | 2013–2014 | |
|---|---|---|---|---|---|
|
| 373 | 487 | 780 | 1192 | 1536 |
| Age | |||||
| Median (IQR) | 31.6 (23.4–45.6) | 33 (22.9–45.3) | 30.7 (21.9–44.8) | 34.4 (23.9–49.3) | 35.3 (24.4–51.8) |
| Gender | |||||
| Male | 277 (74.3%) | 356 (73.1%) | 571 (73.2%) | 834 (70%) | 1056 (68.8%) |
| Female | 96 (25.7%) | 131 (26.9%) | 209 (26.8%) | 358 (30%) | 480 (31.3%) |
| Injury mechanism | |||||
| RTC | 249 (66.8%) | 295 (60.6%) | 433 (55.5%) | 673 (56.5%) | 891 (58%) |
| Fall > 2 m | 36 (9.7%) | 49 (10.1%) | 74 (9.5%) | 141 (11.8%) | 192 (12.5%) |
| Fall < 2 m | 8 (2.1%) | 13 (2.7%) | 26 (3.3%) | 62 (5.2%) | 104 (6.8%) |
| Shooting/stabbing | 63 (16.9%) | 92 (18.9%) | 182 (23.3%) | 224 (18.8%) | 235 (15.3%) |
| Blow(s) | 9 (2.4%) | 14 (2.9%) | 34 (4.4%) | 51 (4.3%) | 67 (4.4%) |
| Other | 8 (2.1%) | 24 (4.9%) | 31 (4%) | 41 (3.4%) | 47 (3.1%) |
| Charlson comorbidity index | |||||
| Not recorded | 21 (6%) | 44 (9.5%) | 79 (10.3%) | 141 (11.8%) | 141 (9.2%) |
| None | 120 (34.1%) | 137 (29.7%) | 201 (26.3%) | 313 (26.3%) | 488 (31.8%) |
| Minor: 1–5 | 89 (25.3%) | 132 (28.6%) | 223 (29.2%) | 307 (25.8%) | 373 (24.3%) |
| Moderate: 6–10 | 71 (20.2%) | 103 (22.3%) | 144 (18.8%) | 237 (19.9%) | 317 (20.6%) |
| Severe > 10 | 51 (14.5%) | 45 (9.8%) | 117 (15.3%) | 194 (16.3%) | 217 (14.1%) |
| Liver severity | |||||
| Median (IQR) | 2 (2–4) | 2 (2–3) | 2 (2–3) | 2 (2–3) | 2 (2–3) |
| Liver isolated | |||||
| No | 309 (82.8%) | 383 (78.6%) | 601 (77.1%) | 955 (80.1%) | 1217 (79.2%) |
| Yes | 64 (17.2%) | 104 (21.4%) | 179 (22.9%) | 237 (19.9%) | 319 (20.8%) |
| GCS on arrival | |||||
| Median (IQR) | 15 (8–15) | 15 (13–15) | 15 (13–15) | 15 (13–15) | 15 (13–15) |
| SBP on arrival | |||||
| Median (IQR) | 125 (102–143) | 120 (102–140) | 122 (104–140) | 122 (103–140) | 123 (105–139) |
| Pulse on arrival | |||||
| Median (IQR) | 96 (80–117) | 95 (78–110) | 93 (76–115) | 93 (78–110) | 90 (75–109) |
| Consultant at ED | |||||
| | 172 (46.1%) | 204 (41.9%) | 430 (55.1%) | 801 (67.2%) | 1254 (81.6%) |
| TXA at ED | |||||
| | 0 (0%) | 0 (0%) | 3 (0.4%) | 196 (16.4%) | 733 (47.7%) |
| CT | |||||
| | 247 (66.2%) | 363 (74.5%) | 617 (79.1%) | 997 (83.6%) | 1357 (88.3%) |
| Time to CT (h) | |||||
| Median (IQR) | 1.58 (0.97–2.5) | 1.43 (0.85–3.12) | 1.27 (0.65–2.9) | 1 (0.52–2.45) | 0.65 (0.35–1.62) |
| Surgery | |||||
| | 212 (56.8%) | 316 (64.9%) | 470 (60.3%) | 649 (54.4%) | 809 (52.7%) |
| Liver surgery | |||||
| | 9 (2.4%) | 13 (2.7%) | 39 (5%) | 75 (6.3%) | 105 (6.8%) |
| Admission to critical care | |||||
| | 220 (59%) | 299 (61.4%) | 478 (61.3%) | 721 (60.5%) | 901 (58.7%) |
| LOS in critical care | |||||
| Median (IQR) | 5 (2–11) | 5 (2–11) | 4 (2–10) | 4 (2–10) | 4 (1–9) |
| LOS | |||||
| Median (IQR) | 11 (4–22) | 11 (5–26) | 9 (5–20) | 9 (4–19) | 9 (5–18) |
Patients undergoing liver specific surgery over the five time periods
| 2005–2006 | 2007–2008 | 2009–2010 | 2011–2012 | 2013–2014 | |
|---|---|---|---|---|---|
|
| 9 | 13 | 39 | 75 | 105 |
| Age | 35.2 (27.2–47.7) | 33.9 (27.3–47.8) | 29.5 (23.3–51.2) | 34.1 (22.4–45.9) | 31.9 (24.5–49.2) |
| Gender | |||||
| Male | 7 (77.8%) | 6 (46.2%) | 31 (79.5%) | 54 (72%) | 71 (67.6%) |
| Grade of liver injury | |||||
| 1 | 0 (0%) | 5 (38.5%) | 8 (20.5%) | 16 (21.3%) | 15 (14.3%) |
| 2 | 4 (44.4%) | 1 (7.7%) | 12 (30.8%) | 17 (22.7%) | 37 (35.2%) |
| 3 | 1 (11.1%) | 2 (15.4%) | 5 (12.8%) | 23 (30.7%) | 24 (22.9%) |
| 4 | 4 (44.4%) | 2 (15.4%) | 9 (23.1%) | 9 (12%) | 20 (19%) |
| 5 | 0 (0%) | 3 (23.1%) | 5 (12.8%) | 8 (10.7%) | 9 (8.6%) |
| 9 | 0 (0%) | 0 (0%) | 0 (0%) | 2 (2.7%) | 0 (0%) |
| Charlson comorbidity index | |||||
| Not recorded | 0 (0%) | 2 (15.4%) | 2 (5.3%) | 5 (6.7%) | 5 (4.8%) |
| None | 3 (33.3%) | 2 (15.4%) | 7 (18.4%) | 20 (26.7%) | 25 (23.8%) |
| Minor: 1–5 | 1 (11.1%) | 6 (46.2%) | 13 (34.2%) | 21 (28%) | 36 (34.3%) |
| Moderate: 6–10 | 2 (22.2%) | 3 (23.1%) | 6 (15.8%) | 18 (24%) | 20 (19%) |
| Severe > 10 | 3 (33.3%) | 0 (0%) | 10 (26.3%) | 11 (14.7%) | 19 (18.1%) |
| ISS | 48 (18–50) | 41 (21–57) | 34 (18–43) | 29 (13–41) | 29 (13–43) |
| SBP on arrival | 104 (86–131) | 95 (82–114) | 99 (75–128) | 106 (80–124) | 111 (92–133) |
| Pulse on arrival | 114 (111–128) | 118 (100–148) | 116 (88–130) | 108 (90–130) | 107 (80–122) |
| HPB unit | 9 (100%) | 6 (46.2%) | 25 (64.1%) | 42 (56%) | 84 (80%) |
| Alive at 30 days | 8 (88.9%) | 9 (69.2%) | 29 (74.4%) | 57 (76%) | 86 (81.9%) |
Logistic regression model for predictors of mortality for hepatic trauma in the year 2005–2014
| Coefficients |
| Odds ratio (OR) | 95% CI for OR | |||
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Model predicting survival | ||||||
| 16–44 (reference) | ||||||
| 45–54 | −0.335 | 0.057 | 0.716 | 0.507 | 1.010 | |
| 55–64 | −0.741 | 0.001 | 0.476 | 0.314 | 0.724 | |
| 65–75 | −1.623 | 0.000 | 0.197 | 0.127 | 0.306 | |
| >75 | −2.699 | 0.000 | 0.067 | 0.044 | 0.104 | |
| Male (reference) | ||||||
| Female | 0.135 | 0.284 | 1.144 | 0.894 | 1.465 | |
| ISS | −0.066 | 0.000 | 0.936 | 0.929 | 0.944 | |
| GCS 15 (reference) | 0.000 | |||||
| GCS = 3 | −3.667 | 0.000 | 0.026 | 0.016 | 0.041 | |
| GCS 4–5 | −2.138 | 0.000 | 0.118 | 0.046 | 0.301 | |
| GCS 6–8 | −1.627 | 0.004 | 0.197 | 0.065 | 0.591 | |
| GCS 9–12 | −2.174 | 0.000 | 0.114 | 0.038 | 0.342 | |
| GCS 13–14 | −1.045 | 0.003 | 0.352 | 0.176 | 0.701 | |
| Intubated | −3.118 | 0.000 | 0.044 | 0.031 | 0.063 | |
| Not recorded | −0.947 | 0.000 | 0.388 | 0.275 | 0.548 | |
| 2005–2009 (reference) | 0.206 | |||||
| 2010–2012 | 0.093 | 0.517 | 1.097 | 0.829 | 1.453 | |
| 2013–2014 | 0.259 | 0.084 | 1.296 | 0.966 | 1.738 | |
| CCI 0 (reference) | 0.000 | |||||
| CCI 1–5 | 0.232 | 0.136 | 1.261 | 0.929 | 1.712 | |
| CCI 6–10 | 0.664 | 0.000 | 1.943 | 1.361 | 2.773 | |
| CCI > 10 | 0.545 | 0.004 | 1.724 | 1.192 | 2.493 | |
| CCI not recorded | −1.090 | 0.000 | 0.336 | 0.236 | 0.479 | |
| Treated in HPB | 1.259 | 0.000 | 3.521 | 2.745 | 4.516 | |
| Constant | 4.550 | 0.000 | 94.661 | |||